Lenograstim
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
|
WikiDoc Resources for Lenograstim |
|
Articles |
|---|
|
Most recent articles on Lenograstim Most cited articles on Lenograstim |
|
Media |
|
Powerpoint slides on Lenograstim |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Lenograstim at Clinical Trials.gov Clinical Trials on Lenograstim at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Lenograstim
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Lenograstim Discussion groups on Lenograstim Patient Handouts on Lenograstim Directions to Hospitals Treating Lenograstim Risk calculators and risk factors for Lenograstim
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Lenograstim |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as a immunostimulator.[1]
References
- ↑ Amadori S, Suciu S, Jehn U; et al. (2005). "Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study". Blood. 106 (1): 27–34. doi:10.1182/blood-2004-09-3728. PMID 15761020.
- Pages with script errors
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes